mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.05 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.05 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.06 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.06 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.06 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.06 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |